The incorporation of non-canonical amino acids into proteins has emerged as a promising strategy to manipulate and study protein structure-function relationships with superior precision in vitro and in vivo. To date, fluorescent non-canonical amino acids (f-ncAA) have been successfully incorporated in proteins expressed in bacterial systems, Xenopus oocytes, and HEK-293T cells. Here, we describe the rational generation of an orthogonal aminoacyl-tRNA synthetase based on the E. coli tyrosine synthetase that is capable of encoding the f-ncAA tyr-coumarin in HEK-293T cells.
INTRODUCTION
The emergence of chemical conjugation and genetic encoding techniques to label proteins with fluorescent probes has enabled significant advances in the mechanistic understanding of proteins in biochemical and cellular environments 1 . Encoding large fluorescent proteins (e.g. GFP) as fusion protein products is experimentally straightforward, however, the relative size of the probes can alter the function and biology of the protein being studied. Alternatively, chemical conjugation of an expressed protein requires the labeling sites are solvent accessible and labeling of cytoplasmic sites often comes with significant background reactivity 2 . A possible solution to these issues is the use of genetic code expansion to introduce a relatively compact fluorescent side chain as a noncanonical amino acid directly into the target protein in a sitespecific fashion 3 . Indeed, the rapid development of genetically encoded fluorophores as a non-canonical amino acids (ncAA) is emerging as a promising strategy to describe protein function under minimal perturbations in eukaryotic cells 3, 4 . The experimental strategy employs an orthogonal suppressor tRNA and an evolved aminoacyl tRNA synthetase (RS), often based upon the tyrosine pair, which can be used to encode the ncAA at virtually any site in the reading frame of the target gene. This pair is orthogonal to the translation system employed, meaning that an evolved TyrRs cannot acylate endogenous Tyr-tRNA molecules and the suppressor tRNAtyr is minimally acylated by host cell synthetases 5 . The orthogonal tRNA has the appropriate anticodon to suppress the nonsense codon, thus allowing for an introduced amber codon of target genes in both prokaryote and eukaryotic systems 3, 5, 6 . This approach has been successfully used for site-specific incorporation of f-ncAA into a soluble proteins in prokaryote cells (dansyl and hydroxycoumarin) 4,7 , membrane proteins expressed in Xenopus leavis oocytes (bodipy and anap) 8, 9 , and proteins expressed in mammalian cells (dansyl and anap) 10, 11 . Hydroxycoumarin is notable because of its small size and high environmental sensitivity 12, 13 , however, no system yet exists for its incorporation via expanding genetic code in mammalian cells.
RESULTS
The incorporation of a 7-hydroxycoumarin amino acid (TyrCoum) has been previously accomplished in E.coli using a Methanococcus jannaschii tyrosyl tRNA (MjtRNA Tyr CUA ) and a tyrosyl-tRNA synthetase (MjTyrRS) 4 . To expand the possible applications for TyrCoum we sought to develop an tRNA/RS pair that is amenable to mammalian expression systems and thus started with the tyrosyl-tRNA synthetase from E. coli (EcTyrRS; PDBID 1X8X; Figure 1a ) 14 , in combination with a suitable tRNA from B. stearothermophilus (BstRNA CUA ) 6 . Evolved versions of this particular orthogonal pair allow for the efficient incorporation of a variety or aromatic ncAA, including p-benzoyl-L-phenylalanine (Bzp) and acetylphenylalanine (Azi) moieties in HEK-293T cells 15, 16 . Structural and structure-function information of the TyrRS was used as starting point for our de-novo design of a TyrCoum RS 14, 17 . First, comparable residues were identified within the amino acid binding region of the EcTyrRS (PDB 1X8X), MjTyrRS (PDB 1ZH6) 18 and structural models of the modified tyrosyl-tRNA synthetases MjCoumRS, EcAziRS, and EcBpaRS. These comparisons were useful as they informed the subsequent selection of RS mutations predicted to increase the size and flexibility of the catalytic domain. Four mutations are predicted to participate in substrate coordination (Y37G, L71H, D182G, and L186G) while five sites (L56E, T76G, S120Y, A121H, and F183I) are located near the catalytic domain and connector peptide region ( Figure 1b ).
The Y37G mutation was introduced to destabilize tyrosine binding 14, 17 and the additional D182G and L186G mutations served to further expand the binding pocket. The L71H and T76G are were reported in MjCoumRS (i.e. L65H and H70G) as crucial on the recognition of coumarin's phenolic ring 4 . S120Y and A212H, whose side chains are pointing out of the binding pocket, were introduced to promote flexibility within the binding region. The final engineered RS containing these nine mutations was termed EcCoumRS (Figure 1b ). As a first pass, f-ncAA docking in silico to the EcCoumRS was examined by generating a molecular model using the structure of EcTyrRS as template. As expected according to the design strategy, the incorporated mutations produce a wider binding pocket with the potential to accommodate larger aromatic side-chains ( Figure 1 c and f). This structural analysis suggests that the f-ncAA substrate, TyrCoum, relies on a new set of hydrogen bonds to bind the catalytic site (Figure1 d and g) and that may preserve the orientation needed to form the end tRNA-amino acid complex ( Figure 1 e and h). In silico derived estimates of binding energy (ΔG binding =ΔG apo -ΔG ligand-bound ), a value grossly related to the binding affinity 27 , suggests that the novel EcCoumRS could also be selective for TyrCoum (ΔG binding =-10 kCal/mol) over natural aromatic side chains (ΔG binding = -8.6, -8.3, -8.0 kCal/mol for Trp, Phe, and Tyr respectively). To test whether this new EcCoumRS/BstRNA tag pair was able to selectively incorporate TyrCoum western blot experiments were performed on HEK-293T cells expressing a mutant fluorescent protein (GFP 40 TAG ) containing a mutation (Y40TAG) that precedes the protein cromophore 16 . This strategy was used to test for rescue of the full-length fluorescent protein in the presence of the f-ncAA (500 nM; Figure 2a ). Consistent with the in silico docking data, a second large fluorescent aromatic ncAA LysNBD (7nitrobenz-2-oxa-1,3-diazol-4-yl) 19 was also encoded by the mutant RS but with lower efficiency ( (Figure 2e ). Additionally, a coumarin signal was not observed in cells that do not express GFP 40 TAG (Figure 2e ). In order to demonstrate subcellular localization, coumarin was encoded at position Y671TAG of TRPV1-YFP, a plasma membrane ion channel chimeric protein that can be observed directly at the membrane by total internal reflection microscopy (TIRF). Here, the distinct emission spectra of coumarin and YFP demonstrated the encoded organic and protein fluorophores are indeed colocalized (Figure 2f ).
DISCUSSION
The present study describes the design of an in silico designed amber suppressor tRNA/aminoacyl-tRNA synthetase pair for encoding Tyr-coumarin, EcCoumRS. The approach takes advantage of the available structural and functional data on RS proteins from bacterial and eukaryotic systems that have been used previously to generate amber suppression-based genetic code expansion approaches. It has been reported that the substrate binding process in EcTyrRS is supported by polar interactions where D182 binds the natural substrate (i.e. Tyrosine) and when the substrate is absent D182 is stabilized by polar interactions with neighbor residues 17 . For the case of TyrCoum, the mutations on residues D182G, F183I and L186G not only widen the cavity hosting the bulkier substrate but also provide internal contacts in which G182 is limited to interact with L178 alone; I183 is at short distance from Q179, G180, and N187; and G186 can be stabilized by contacting Y190, G191 and V192. Our docking simulations suggest that G182 changes the orientation of the alpha helix containing it, favoring ligand binding. Deeper within the binding pocket, I183 and G186 are facing away from the substrate binding site, where the modeling suggests that they are coordinated by neighboring residues. Overall, the data support the feasibility of our design strategy of de-novo design where EcCoumRS yields hydroxycoumarin-containing proteins for single cell imaging and biochemical scale expression and is able to encode the f-ncAA NBD, albeit with lower yields. Further experiments including in vitro evolution-guided selection of the EcCoumRS might produce more selective enzymes for these two fluorophores. In summary, we are reporting a robust tool to incorporate an environmentally sensitive f-ncAAs such as hydroxycoumarin in eukaryotic proteins of living cells, useful will for live cell imaging and spectroscopic studies in native systems, without the need for additional purification procedures.
EXPERIMENTAL PROCEDURES
Molecular Biology. The gene encoding CoumRS was constructed with overlapping PCRs, using BpaRS as primary template. Oligonucleotides used for the aminoacyl-tRNA synthetase mutations were (mutated nucleotides are underlined): a) 5'-CTTGTTCCATTGGAATGCCTGAAACGC -3'; (L56E). b) 5'-AAGCCGGTTGCGCACGTAGGCGGCGCGGGGGGTCTGA TTGGC -3'; (H71L , T76G). c) 5'-TGTGGAGAAAACTATCATATCGCGGCGAAC -3'; (S120Y , T121H). d) 5'-TTGCAGGGTTATGGCATCGCCTGTGGGAACAAACAGT ACG -3'; (D182G , M183I , A186G). Oligonucleotides used for the incorporation of restriction sites into the cassette encoding the synthetase were (initiation and termination codons are underlined): C-terminal e) 5'-GTTTAAACTTAAGCTTGGTACCCCACCATG -3'; (HindIII). N-terminal f) 5'-GACGACAAGTAATCTAGAGGGCCCGTTTAA -3'; (XbaI). The plasmid encoding the tRNA UAG (pSVBpUC) was obtained from Thomas P. Sakmar Laboratory. PCRs were done with PfuUltra II Fusion HSD DNA polymerase from Agilent Technologies, according to the manufacturer's instructions. Synthesis of f-ncAAs. Synthesis of TyrCoum. L-(7hydroxycoumarin-4-yl) ethylglycine was obtained as described before 4 . Synthesis of NBD-lysine. Na-(t-Butoxyccarbonyl)-L-lysine (308 mg, 1.25 mmol) was dissolved in a 3% solution of sodium bicarbonate in water (13 mL) in a 100 mL roundbottom flask equipped with a stir bar, and heated to 37°C. A solution of NBD-Cl (7-chloro-4nitrobenz-2-oxa-1,3-diazole) (500 mg, 2.5 mmol) in 95% ethanol (35 mL) was slowly introduced via Pasteur pipet over 20 minutes. Following ~8 hours of stirring the reaction mixture was acidified to pH ~1 by the addition of 6M HCl and extracted 3 times with dichloromethane. The organic phase was washed with saturated sodium bicarbonate and the aqueous layer retained. 6M HCl was added with rapid stirring in the presence of dichloromethane to lower the pH until the desired product came out as a yellow cloud. The acid mixture was extracted with more dichloromethane, the organic fractions combined and dried over anhydrous magnesium sulfate and placed on a rotary evaporator until a brownish residue was obtained. The purity of the product was estimated at ~90% based on TLC analysis. Without further purification the product was dissolved in dichloromethane (5 mL) and trifluoroacetic acid was slowly added (20 mL) and the solution was stirred at room temperature for 2 hours until TLC showed no t-BOC remained on the compound. The reaction was then concentrated under vacuum to yield a dark, oily solid. Bioinformatics. Structure models for AziRS, BpaRS and CoumRS were made with Modeller 9.13 (Andrej Sali Lab, UCSF), using as template the X-ray structure of E. coli TyrRS in complex with Tyr-AMS (PDBID 1X8X) 20 . The sequence identity obtained from the pairwise alignment of E. coli TyrRS with AziRS, BpaRS, and CoumRS were 98.6%, 98.8%, and 95.8% respectively. Molecular docking simulations were performed in parallel using two different engines: i) Autodock Vina docking software (Molecular Graphics Lab, The Scripps Research Institute) and ii) the online server SwissDock (Swiss Institute of Bioinformatics, Molecular modeling group). Docking was guided within a grid calculated with Autodock Vina as: volume coordinates dimensions X=46, Y=24, Z=34, centered on X=12.825, Y=29.431, Z=19.000, with 0.436Å spacing. To first evaluate our docking strategy, we performed docking studies using Tyr ligand on the TyrRS crystal structure (1X8X, ligand removed) and calculate the RMSD for the position of the docked Tyr when compared to the Tyr at the crystal structure.
To find a list of potential mutations implied in the ligand binding, an alanine screening was performed into Tyr binding pocket. The structures mutated were used as new receptors of Tyr and TyrCoum in docking calculations. From the obtained set of ΔG binding , we chose the best scores for docked ligands taking in consideration both the RMSD from Autodock Vina (RMSDd/l and RMSDu/b) together with the full-fitness value from Swiss-Dock. Molecular graphics and analyses of ligand structures were performed with the UCSF Chimera package (University of California, San Francisco). Cell culture. HEK293T cells, were cultured in DMEM (Gibco Inc.) supplied with 10% FBS (Gibco Inc.). Cells were prepared at (60-70)% confluence and transfected with lipofectamine 2000 following the instructions from the provider (Life technologies). The target gene was transfected 2-3 hours after an initial transfection of the tRNA tag /EcCoumRS pair. The f-ncAA was added to cell cultures to a final concentration of 0.5 to 5 µM together with the second transfection procedure. Western Blots. The existing media was aspirated and the cells washed with ice-cold PBS containing a cocktail of protease inhibitors (Roche), dispatched from the dish using a cell lifter and transferred to pre-chilled 1.5 mL tubes. The cells were then centrifuged (21000 x g; 4°C) for 5 minutes and the supernatant discarded. The cell pellets were vortexed in 100 µL of cell lysis buffer, and protease inhibitors for 10 min in a cold room. The samples were then centrifuged (21,000 x g; 4°C) for 20 min. Protein quantification was done using Bradford Protein Assay. 80 µg total protein of each sample (20 µg of TyrRS positive control) run on a 4-20% PAGE gel (pre-cast, Biorad). Proteins were then transferred onto a nitrocellulose membrane with cold pack (room temp); 5% milk blocking for 2 hr at room temp was followed by overnight incubation with the primary antibody (1:10,000; anti-GFP rabbit polyclonal; Synaptic Systems). Secondary incubation was performed for 2 hr at RT (1:10,000; Goat Anti-Rabbit IgG HRP Conjugate; Millipore). Membranes were incubated with house ECL for 2 minutes and exposed every 1 min for 20 min. Imaging. 24 hours after target gene transfection, cells were disaggregated and plated on poly-L-lysine treated glass covers. The f-ncAA-containing media was removed at least 12h prior the experiment allowing cells to clear the soluble f-ncAA and the cells were imaged 36-48 hours after the second transfection using an inverted Olympus IX71 microscope. 405nm and 473nm solid-state lasers (Laser Glow) were focused to the backplane of a high-numerical aperture objective (Olympus 60X, N.A. 1.49, oil) by a combination of focusing lens. Fluorescence emission was collected by a EMCCD camera (Andor iXon EM 860), after passing through an emission filter according to each acquisition wavelength band of interest (coumarin:450/70; YFP:540/40; Semrock). Excitation light was controlled by a 12mm mechanical shutter (Vincent associates). All imaging experiments were done at room temperature (20-22°C). Laser and focus control was performed using micromanager. Acquisition and digitalization was done with Andor Solis software.
